ACTIVE

Apotheek LA Pharma Groep

Financial year 2025 · Closed on 31/12/2025

Net result27,8 k €+353,3 %over 1 year
Gross margin162,6 k €-20,2 %over 1 year
Equity-74,1 k €+27,3 %over 1 year

Identity

Source · BCE/KBO

Apotheek LA Pharma Groep is a Private limited company incorporated in 2021. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Beveren-Kruibeke-Zwijndrecht.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0773.962.703
Incorporation
16/09/2021
Legal form
Private limited company
Registered office
Geeraard de Cremerstraat 12
9150 Beveren-Kruibeke-Zwijndrecht · FlandreSee on map
Contributed capital
20 000,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 3130
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 4 filings

Trend over 4 financial years

2025202420232022
Income statement
Gross margin162,6 k €203,8 k €148,1 k €184,8 k €
EBITDA123,3 k €72,1 k €6,9 k €73,5 k €
Operating result54,3 k €3,1 k €-62,1 k €-16,4 k €
Net result27,8 k €-11 k €-75 k €-36 k €
Balance sheet
Equity-74,1 k €-101,9 k €-91 k €-16 k €
Total assets730,9 k €825 k €866,2 k €936,8 k €
Cash8,4 k €46,4 k €8,4 k €8,4 k €
Debts805,1 k €926,9 k €957,1 k €952,8 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

Maxime Van Eetvelde

Director · since 15 septembre 2021

Active

Ended mandates

Maxime Van Eetvelde

Director

Ended

Other companies at this address

Geeraard de Cremerstraat 12 9150 Beveren-Kruibeke-Zwijndrecht
CompanyCBE no.
0506.644.064
1021.147.605

Full financial information

Source · NBB
2025202420232022
Type of accountMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202316/09/2021
Closing of the financial year31/12/202531/12/202431/12/202331/12/2022
Length of the financial year12 months12 months12 months16 months
Filing date20/07/202604/08/202520/06/202410/08/2023
General meeting30/06/202615/06/202516/06/202401/08/2023
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202530/06/202620/07/2026DutchPDF
Micro model31/12/202415/06/202504/08/2025DutchPDF
Micro model31/12/202316/06/202420/06/2024DutchPDF
Micro model31/12/202201/08/202310/08/2023DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

Maxime Van Eetvelde

Director · since 15 septembre 2021

Active

Ended mandates

Maxime Van Eetvelde

Director

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other20/09/2021
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202527,8 k €↑
  2. 2024
    Annual accounts 2024-11 k €↑
  3. 2023
    Annual accounts 2023-75 k €↓
  4. 2022
    Annual accounts 2022-36 k €
  5. 16/09/2021
    IncorporationPrivate limited company